Russian pharma sector growing despite unprecedented sanctions

The Russian pharmaceutical sector is steadily developing despite the ongoing military conflict in Ukraine and the ever-tightening sanctions pressure against the country, according to recent statements by some leading local pharma analysts and Russian media, reports The Pharma Letter’s local correspondent.

The current positive dynamics of the industry are reflected by the ever-growing production and the number of clinical trials on drug candidates that are being conducted by local drugmakers.

This is confirmed by recent statements of the First Deputy Head of the Ministry of Industry and Trade of Russia, Vasily Osmakov, according to whom, since February, 24 domestic pharmaceutical companies have increased the number of clinical trials of their new potential drugs by almost 30%, while the growth is currently ongoing.